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Abstract.— A model is proposed for the evolution of X chromosome inactivation (XCI) 
in which natural selection initially favors the silencing of paternally-derived alleles of X-
linked demand inhibitors. The compensatory upregulation of maternally-derived alleles 
establishes a requirement for monoallelic expression in females. For this reason, XCI is 
self-reinforcing once established. However, inactivation of a particular X chromosome is 
not. Random XCI (rXCI) is favored over paternal XCI because rXCI reduces the costs of 
functional hemizygosity in females. Once present, rXCI favors the evolution of locus-by-
locus imprinting of X-linked loci which creates an evolutionary dynamic in which 
different chromosomes compete to remain active. 
 
Key words: dosage compensation, genomic imprinting, parental antagonism, sexual 
antagonism, X-chromosome inactivation 
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Female mammals possess two X chromosomes, one inherited from each parent. 
Males, on the other hand, possess a single X inherited from their mother. Despite this 
two-fold difference in gene dosage, a single X-linked allele is expressed in XX as well as 
XY nuclei, because one of the X chromosomes in XX nuclei of differentiated cells is 
transcriptionally inactive (Plath et al. 2002).  
The function of X chromosome inactivation (XCI) is commonly assumed to be 
dosage compensation. That is, XCI is believed to have evolved as a mechanism to 
equalize the level of expression of X-linked loci in the two sexes. XCI is a strange way to 
equalize expression, however, because females forgo some of the advantages of having 
two functional copies of each X-linked locus. In Caenorhabditis and Drosophila, dosage 
is compensated without this disadvantage by the simple expedient of having the single X 
of males expressed at twice the level of each X chromosome of females (Parkhurst and 
Meneely 1994). XCI is also a strange mechanism in that homologous, sometimes 
identical, sequences have different expression in the same nucleus. XCI shares both of 
these peculiar features with genomic imprinting and an evolutionary connection between 
the two epigenetic phenomena has often been suggested (e.g., Ohlsson et al. 2001; Lee 
2003a; Huynh and Lee 2005; Reik and Lewis 2005) 
Five considerations suggest that genomic imprinting and XCI may be conceptually 
and mechanistically related. First, both are processes that forgo the partial protection that 
diploidy provides against the effects of deleterious somatic or germline mutations 
(Sapienza 1989; Charlesworth 1996). Second, both are processes by which different 
copies of a DNA sequence have different behaviors within a single nucleus (Hendrich 
and Willard 1995). Third, parental origin determines which X chromosome is inactivated   4 
in marsupials (Cooper et al. 1971; Sharman 1971) and extraembryonic tissues of cattle 
(Xue et al. 2002), rats (Wake et al. 1976), and mice (Takagi and Sasaki 1975). Fourth, the 
kinds of genes that are predicted to be subject to imprinting are also the kinds of genes 
for which dosage compensation should be important. That is, both processes are expected 
to have evolved because of genes whose effects are dosage sensitive. For most loci at 
which the effects of loss-of-function mutations show recessive inheritance, effects on the 
phenotype are dosage-insensitive and there would be only weak selection for dosage 
compensation, just as there would be only weak selection for imprinting (Haig 1997). 
Fifth, the mechanisms of XCI and imprinted allele inactivation share common molecular 
machinery (Lee 2003a; Mager et al. 2003; Silva et al. 2003). 
Haig and others (see papers collected in Haig 2002) have argued that genomic 
imprinting has evolved in mammals because of conflicting selective forces acting on 
genes of maternal and paternal origin. Situations in which selection acts differentially 
with respect to parental origin have been termed parental antagonism by analogy to 
sexual antagonism which arises when a gene’s expression benefits one sex but not the 
other (Haig 1997). Parental antagonism arises in the context of interactions with kin that 
are unequally related to an individual via the individual’s mother and father. Interactions 
subject to parentally-antagonistic selective forces include, but are not restricted to, an 
individual’s interaction with its parents. The evolution of parental origin-limited gene 
expression at a locus subject to parental antagonism is analogous to the evolution of sex-
limited expression at a locus subject to sexual antagonism (Haig 1997). 
One situation in which matrilineal and patrilineal interests diverge is over the level of 
demand that offspring impose on their mothers, with patrilineal interests favoring higher   5 
levels of demand than matrilineal interests. The balance of forces differs between X-
linked and autosomal loci because all eggs, but only 50% of sperm, carry an X 
chromosome, whereas every gamete carries a copy of each autosome. As a consequence, 
X-linked genes are predicted to display an evolutionary bias favoring matrilineal 
interests, including lower levels of demand by offspring for maternal resources (Haig 
2000a, 2000b, 2006). For this reason, Haig (2000a) suggested that imprinted (paternal) X 
inactivation may have evolved because paternally-derived X-linked alleles gained an 
advantage from shutting down their own chromosome to reduce the effective dosage of 
demand inhibitors, thus favoring patrilineal interests over matrilineal interests. The 
current paper develops this hypothesis in greater detail.  
EVOLUTION OF X INACTIVATION 
Preliminaries 
The model that will be presented in subsequent sections is based on the premise that, 
prior to the origin of XCI, genes on the X chromosome functioned to reduce the level of 
demand that offspring imposed on their mothers. Haig (2006) has called this the 
hypothesis of X-Linked Inhibitory Bias (XLIB). In that paper, I present reasons for this 
theoretical prediction and review evidence that bears on this prediction. Briefly, genes on 
the X chromosome are predicted to favor maternal interests because alleles at X-linked 
loci are maternally-derived two-thirds of the time by contrast to alleles at autosomal loci 
that are maternally-derived half of the time (also see Mills and Moore 2006). Relevant 
data are limited and XLIB is neither strongly supported nor refuted. The present paper 
does not repeat these arguments but develops a scenario for the evolution of XCI given 
the assumption that XLIB is correct. The scenario addresses the evolution of expression   6 
levels in females but does not consider the evolution of expression levels in males. First, I 
use the predicted bias in favor of demand inhibitors on X chromosomes to develop a 
model for the origin of paternal X chromosome inactivation (pXCI) and then present a 
model for the subsequent origin of random X chromosome inactivation (rXCI). If XLIB 
is refuted, the scenario will fail. 
In the absence of genomic imprinting, the aggregate level of expression (from both 
alleles) of a demand inhibitor is predicted to be a compromise between a higher level 
favored when an allele is maternally derived and a lower level favored when the allele is 
paternally derived. If the locus is subject to genomic imprinting, the evolutionarily stable 
strategy (ESS) for an allele is to be expressed at the higher (maternal) optimum when 
maternally derived but to be silent when paternally derived. This prediction has been 
termed the “loudest-voice-prevails” (LVP) principle. The prediction that one allele 
should be silenced at the ESS presupposes that maternally-derived and paternally-derived 
alleles of a diploid individual contribute their gene product to a common pool, the size of 
which determines effects on fitness (Haig 1997, 2006). The principle does not apply to 
genes with cell-autonomous effects that are subject to rXCI because then maternally-
derived and paternally-derived alleles are expressed in different cells. 
I will use the adjectives madumnal to refer to maternally-derived alleles or 
chromosomes and padumnal to refer to paternally-derived alleles or chromosomes. Haig 
(1996) introduced this terminology because ambiguities can arise in discussions of the 
evolution of genomic imprinting if maternal and paternal can be used to refer either to 
genes present in mothers and fathers or to genes derived from mothers and fathers present 
in offspring. Queller (2003) has suggested the more euphonious matrigenic and   7 
patrigenic to make the same distinction. I am happy for popular usage to determine 
which pair of terms, if either, is broadly adopted. 
 
Origin of padumnal X inactivation 
In the presence of genomic imprinting, natural selection favors the inactivation of 
padumnal alleles at demand-inhibitor loci and an associated up-regulation of madumnal 
alleles to more than compensate for padumnal silence (Haig 2006). This immediately 
suggests an evolutionary model for the origin of padumnal X-chromosome inactivation 
(pXCI). Natural selection favored reduced expression of the padumnal alleles of X-linked 
demand inhibitors because this action increased demand while at the same time reducing 
the component of cost due to production of the demand inhibitors. Two variants of the 
model can be considered: coalescence of inactivation from multiple centers or diffusion 
of inactivation from a single center. Under the first variant, padumnal inactivation 
evolved independently at multiple demand inhibitor loci. Inactivation then spread to 
intervening loci, perhaps for reasons of mechanistic efficiency and chromatin structure, 
or for reasons of dosage compensation. Under the second variant, natural selection 
favored a padumnally-expressed agent within the X-linked block that caused the down-
regulation of loci in cis. 
The proposed advantage to an agent on the padumnal X (X
P) of inactivating its own 
chromosome would also apply if the agent inactivated the madumnal X (X
M), or a 
random X, instead. Inactivation of X
M or a random X would have been evolutionarily less 
stable than inactivation of X
P, however. This is because genes on X
P would have 
benefited from reduced expression of X-linked demand inhibitors, whereas genes on X
M   8 
would have been disadvantaged by reduced expression of demand inhibitors. X-linked 
genes would therefore be selected to avoid inactivation when maternally-derived but to 
facilitate inactivation when paternally-derived.  
Unimprinted autosomal genes (or padumnally-expressed autosomal genes) would also 
have benefited from decreased expression of X-linked demand inhibitors, because 
autosomal loci are not subject to the matrilineal bias of X-linked loci. However, I favor a 
hypothesis in which the primary mutations occurred on the X chromosome because an 
autosomal location would not explain specificity of inactivation for X
P. (In the absence of 
genomic imprinting of X-linked loci there would be no reason why trans-acting factors 
should discriminate between X chromosomes on the basis of parental origin.) 
Nevertheless, natural selection on autosomal loci is unlikely to have opposed the early 
stages in the evolution of pXCI. 
The short-term effect of the origin of pXCI would be to reduce the expression of X-
linked demand inhibitors. The long-term effect would be the opposite. Before pXCI, the 
expression of a demand inhibitor is a matrilineally-weighted compromise between 
madumnal and padumnal interests. Under the diffusion model, one locus, the imprinted 
cis-inactivator on the padumnal X, is subject to selection solely on its effects when 
paternally-derived whereas the inactivated loci are subject to selection solely on their 
effects when maternally derived. The change in selective forces that accompanies the 
origin of pXCI favors increased expression of X-linked demand inhibitors, and intensifies 
selection on the cis-inactivator to prevent reactivation of its own chromosome. That is, 
the LVP principle predicts that the upregulation of madumnal alleles of X-linked demand 
inhibitors proceeded in concert with the downregulation of padumnal alleles. The   9 
resultant high-level of madumnal expression would have created a selective force against 
the reactivation of padumnal alleles. Moreover, the evolutionary adjustment of expression 
levels in the context of a single active X would provide a selective force acting across all 
loci, both autosomal and X-linked, against reactivation of the silent X. As additional loci 
became subject to XCI—whether or not the loci were involved in the inhibition of 
demand—natural selection would adjust the expression level of their single active allele 
in females to accommodate functional hemizygosity at the locus, further reinforcing 
selection against reactivation of the inactive X. 
The above scenario assumes that pXCI evolved from a state in which both X 
chromosomes were active in females, but is not contingent on the presence or absence in 
this ancestral mammal of a pre-existing form of dosage compensation, nor on the 
presence or absence of functional homologs of X-linked alleles on the Y chromosome. 
All that is required is that there had been sufficient selection on X-linked loci for these to 
show a matrilineal bias in their effects and that some of these parentally-antagonistic 
effects were dosage sensitive. Given these conditions, natural selection would favor 
padumnally-expressed factor(s) that reduced expression of X-linked loci. 
The model would be unable to explain the evolution of pXCI from rXCI. If dosage 
compensation by rXCI were already in existence, and X-linked loci were unimprinted, a 
padumnally-expressed agent would gain nothing in terms of reduced expression of 
demand inhibitors by replacing rXCI by pXCI. If there were significant pre-existing 
imprinting of X-linked loci, X
P would be a weaker demand inhibitor than X
M. Thus, there 
would be no incentive for an imprinted agent on either X to shut its own chromosome   10 
down, although there would be a potential advantage for agents on X
P to shut down X
M, 
and vice versa. 
 
Phylogeny of X inactivation 
Phylogenetic comparisons currently provide little evidence with which to test the 
prediction that pXCI is ancestral to rXCI. pXCI has been described from both Australian 
and New World marsupials (Cooper et al. 1993) and therefore is probably ancestral for 
all living marsupials. rXCI is often tacitly assumed to occur in all eutherian mammals 
but, has in fact, been described in only a few species. The best evidence comes from mice 
and humans. Recent phylogenies place both species in the Euarchontoglires, one of four 
major clades of extant eutherian mammals (Murphy et al. 2001). Good evidence also 
exists for rXCI in cats (Lyon 1974) and cattle (Xue et al. 2002), both members of the 
Laurasiatheria. Thus, rXCI appears to have been present in the common ancestor of 
Boreoeutheria, the clade that unites Euarchontoglires and Laurasiatheria (Amrine-
Madsen et al. 2003). Data for the remaining major clades of eutherian mammals are very 
limited. Jegalian and Page (1998) observed methylation of the CpG island associated 
with X-linked ALD in female, but not in male, elephants (Afrotheria) and giant anteaters 
(Xenarthra). They interpreted this sex difference as evidence for XCI in these species but 
had no information about which X was inactive. Available evidence on XCI in 
monotremes—even on the basic question of whether or not XCI occurs—is sufficiently 
sketchy to allow few inferences about the ancestral state of XCI in the monotreme-therian 
ancestor, or to use monotremes as an outgroup to make inferences about the nature of 
XCI in the marsupial-eutherian ancestor (for reviews see Cooper et al. 1993; Graves   11 
1996). On the basis of the known phylogenetic distribution of the two kinds of 
inactivation, it would be equally parsimonious to conclude that pXCI was ancestral to 
rXCI, or the reverse. 
Data on molecular mechanisms are little help in resolving the evolutionary 
relationship between marsupial pXCI and eutherian rXCI, because nothing substantive is 
known about the mechanism of pXCI in marsupials. Some X-linked loci of marsupials 
show partial escape from pXCI in a complex pattern that differs among loci, tissues, and 
species (Cooper et al. 1993). This variability is perhaps more consistent with a model in 
which pXCI in marsupials has evolved independently at multiple loci than one in which 
there is a single center of XCI. 
The selective forces that have been proposed to favor the evolution of genomic 
imprinting and pXCI—namely a protracted relation between mother and offspring—
appear to exist in both monotremes and marsupials. The principal demands of offspring 
upon mothers occur during lactation in these groups, and thus it is principally inhibitors 
of lactational demand that are predicted to be concentrated on the X chromosome. 
“Placental” demands however do potentially exist in both groups because the 
extraembryonic membranes of monotreme eggs absorb nutrients in utero (Hughes 1993) 
and marsupial fetuses possess a yolk sac placenta (Harder et al. 1993). Igf2 and Igf2r are 
the first genes to have been tested for imprinting in monotremes and marsupials. Neither 
gene appears to be imprinted in monotremes, whereas both genes are imprinted in 
marsupials (Killian et al. 2000, 2001a, 2001b; O’Neill et al. 2000). Further research will 
be necessary to uncover the genetic basis of lactational demand and to determine the 
chromosomal location and expression patterns of nursing-related genes in these groups.   12 
 
Origin of random X inactivation 
Although selection for inactivation of an X chromosome, once established, is self-
reinforcing, selection for inactivation of a particular X is not. Padumnally-silent loci are 
never subject to selection for their effects when paternally derived. Therefore, an X
P 
released from pXCI would initially be functionally interchangeable with an active X
M and 
its expression would serve matrilineal interests (Moore et al. 1995). All genomic factions 
would at first benefit from replacing pXCI with random X-chromosome inactivation 
(rXCI) because the independent, random inactivation of X
M and X
P in different cell 
lineages would restore some of the advantages of functional heterozygosity for X-linked 
genes (Charlesworth 1996). The replacement of pXCI by rXCI however would mean that 
X-linked loci were now subject to selection on their effects when paternally derived. This 
would create an opportunity for the evolution of locus-by-locus imprinting on the X 
chromosome. Natural selection would favor the down-regulation of the padumnal alleles 
of X-linked demand inhibitors, but not necessarily their silencing, because the LVP 
principle does not apply at loci subject to rXCI. Therefore, imprinting of loci subject to 
rXCI may show quantitative differences between madumnal and padumnal alleles in 
expression levels, rather than the all-or-none qualitative differences observed at imprinted 
autosomal loci (Haig 2000a). 
The argument for the evolutionary instability of pXCI is a two-edged sword. It 
provides an explanation for the origin of rXCI from pXCI in an ancestor of eutherian 
mammals, but does not provide a compelling explanation for why pXCI is maintained in 
marsupials and murine trophoblast. In the case of marsupials, one might appeal to   13 
phylogenetic inertia and the difficulty of evolving rXCI. Lee (2003a) has argued that 
pXCI in marsupials, unlike rXCI, does not require a counting mechanism to ensure that 
one, and only one, X chromosome is active in each cell. Perhaps coordination between 
homologs to determine which remains active is the “high hurdle” to the origin of rXCI 
that explains the persistence of pXCI in marsupials. But this argument does not help in 
the case of murine trophoblast because mechanisms of rXCI exist in somatic cells of mice 
and rXCI has been described from human trophoblast (Willemsen et al. 2002; Zeng and 
Yankowitz 2003). I will argue below that pXCI in trophoblast, unlike pXCI in 
marsupials, may have evolved from rXCI. 
 
rXCI as a competitive process 
Once rXCI is established and has an obligate role in dosage regulation, the evolution 
of locus-by-locus imprinting on the X chromosome creates a competitive dynamic with 
respect to the choice of which X chromosome remains active. X
P will be less inhibitory 
than X
M in its effects on demand. Therefore, the two X chromosomes should compete to 
be the one that remains active, particularly in tissues that mediate demand. If so, pXCI in 
mouse trophoblast, unlike pXCI in marsupials, may have evolved from rXCI and 
involved X
M forcing its less inhibitory homolog to shut down. Such a form of “enforced” 
pXCI is evolutionarily unstable in the short and long-term. In the short-term there is 
selection on the padumnal X to resist inactivation. In the long-term, if the madumnal X 
wins out, X-linked genes cease to be selected when paternally derived, thus favoring a 
reversion to rXCI (see previous section). Two factors possibly constrain competition to 
inactivate one’s homolog. First, marginal increases or decreases in demand (as would   14 
result from small biases in inactivation) will, respectively, benefit patrilineal and 
matrilineal interests. However, large biases might cause large changes in demand that are 
in neither chromosome’s interests. Second, the greater the bias in inactivation, the closer 
the approach to functional hemizygosity with its associated costs. 
pXCI has been reported from preimplantation mouse embryos (Huynh and Lee 2003; 
Mak et al. 2004; Okamoto et al. 2004) and extraembryonic tissues of cattle (Xue et al. 
2002), rats (Wake et al. 1976), and mice (Takagi and Sasaki 1975), as well as humans 
(Harrison 1989). Recent data, however, suggest that XCI in human trophoblast is 
“random” (Willemsen et al. 2002; Zeng and Yankowitz 2003). There may also be 
exceptions to pXCI in mouse trophoblast. Huynh and Lee (2001) have hypothesized that 
pXCI in mouse trophoblast is “leaky” and that a subset of cells may inactivate the 
madumnal rather than the padumnal X. Hadjantonakis et al. (2001) have reported that 
both X chromosomes are active in trophoblast giant cells of mice. If rXCI is a 
competitive process in which different chromosomes vie to remain active, the observed 
cases of pXCI in trophoblast may simply lie at one end of a continuum of progressively 
greater skew as to which chromosome is inactivated. The difference between pXCI in 
mouse trophoblast and rXCI in human trophoblast would then be quantitative rather than 
qualitative. 
The mechanisms that determine which X chromosome is to be inactivated in murine 
trophoblast are still poorly understood, but some data are compatible with a model in 
which X
M “refuses” to shut down, thus forcing the inactivation of X
P. For example, 
neither copy of X
M is inactivated in X
MX
MY and X
MX
MX
P blastocysts—in the latter case 
X
P is inactivated—but rXCI is reported in X
PX
P androgenetic embryos (Goto and Takagi   15 
2000; Okamoto et al. 2000). This could be viewed as the outcome of an evolutionary 
process in which X
M has gained the upper hand in competition with X
P to remain active in 
trophoblast.  
Evidence to test the hypothesis that X
M and X
P are in competition to remain active in 
somatic cells may come from an understanding of the mechanisms of skewed X-
inactivation caused by natural genetic variation at the X-inactivation center. Such 
variation has been reported in mice (Cattanach 1975) and humans (Plenge et al. 1997; 
Pugacheva et al. 2005). Falconer and colleagues (Falconer and Isaacson 1972; Falconer et 
al. 1982) were able to select for increased and decreased expression of the brindled 
phenotype in mice (a phenotype due to ‘random’ inactivation of alleles at an X-linked 
coat color locus). The response to selection could be due either to skewed XCI or to 
differential survival of cells with different active alleles. Of particular interest, the 
proportion of cells expressing the brindled allele in heterozygous females depended on 
parental origin, suggesting an imprinting effect. 
The Tsix transcript (antisense to Xist) of mice clearly plays an important role in pXCI 
in trophoblast and rXCI in somatic cells (Lee 2000). However, it is currently 
controversial whether this role is conserved in humans (Migeon 2003; Lee 2003b). A lack 
of conservation of basic mechanisms of XCI would be compatible with a model in which 
there is ongoing conflict over which X remains active. 
 
PAM and its precursors 
Previous sections have presented a model of the origin of XCI that I will call the 
parental antagonism model (PAM). PAM proposes that pXCI preceded rXCI and that   16 
pXCI evolved because of intragenomic conflicts between madumnal and padumnal 
alleles. PAM further proposes that XCI, once established, is self-reinforcing because it 
acquires a role in dosage regulation, but that pXCI is evolutionarily unstable because of 
the inherent advantages of rXCI. Once rXCI is established, however, imprinting of X-
linked loci leads to competition between X
M and X
P to remain active. 
PAM is not the first model to attempt to explain the evolution of pXCI in terms of the 
demands that mammalian offspring make on their mothers. Moore and Haig (1991) 
argued that equalization of gene dosage between the sexes requires pXCI if there is 
selection for genomic imprinting, because then both sexes have a single active madumnal 
X chromosome. Up-regulation of the single X in males, as occurs in Drosophila, would 
not equalize expression between the sexes if X-linked genes are imprinted because males 
lack a padumnal X chromosome. In our view, rXCI was favored over pXCI in tissues 
where there was relatively weak selection for imprinting; pXCI was seen as being 
imposed on X
P whereas rXCI was self-enforced. My implicit assumption, at the time, was 
that X
P expressed demand enhancers whose expression was suppressed by other elements 
of the genome. My current views, as expressed in PAM, differ from this earlier model in 
two important respects. First, the X chromosome carries demand inhibitors rather than 
enhancers. Second, PAM does not invoke a need to equalize dosage between the sexes. I 
consider the earlier model to be superseded by PAM. 
In a subsequent paper, Moore et al. (1995) proposed that the presence of a double 
dose of X-linked demand enhancers in females caused female offspring to receive more 
resources than male offspring (contra PAM, which invokes X-linked demand inhibitors). 
The resulting sex-ratio distortion created the selective force favoring reduced expression   17 
of demand enhancers in female embryos. This was achieved by the inactivation of X
P 
after fertilization by maternally-encoded modifiers acting in trans. Moore et al. (1995) do 
not provide any clear justification of why it should be X
P that is inactivated because their 
assumption that demand enhancers were expressed in double dose in females implies that 
the two X chromosomes were functionally interchangeable. Although I consider that 
Moore et al. (1995) have provided an inadequate explanation for the origin of XCI, parts 
of their paper are strong. In particular, they argue that the origin of pXCI caused X-linked 
genes to be subject to selection only on their effects when maternally derived and that 
this favored replacement of pXCI by rXCI. This anticipates arguments used in PAM. 
Reik and Lewis (2005) have recently proposed that pXCI replaced an ancestral 
mechanism of dosage compensation because of selection to reduce the padumnal 
expression of X-linked growth suppressors. This scenario is clearly similar to PAM, 
although the authors provide no detailed discussion of the selective forces involved, 
including no explanation as to why the X chromosome should carry growth suppressors 
rather than growth enhancers. 
 
Comparisons with the dosage-compensation model 
The standard model for the evolution of XCI invokes a need for dosage compensation 
brought about by the degeneration of genes on the mammalian Y chromosome 
(Charlesworth 1978, 1996; Jegalian and Page 1998). In this model, the degeneration of 
Y-linked genes (step 1) favored increased expression of their X-linked homologs (step 2) 
because of benefits to males. Increased expression in males was associated with a 
correlated, but maladaptive, increase of expression in females that created a selective   18 
force favoring the sex-limited down-regulation of X-linked genes in females (step 3). In 
mammals, this down-regulation was achieved by silencing one of the two X 
chromosomes in females. I will call this the sexual-antagonism model (SAM) of XCI 
because the up-regulation of X-linked expression in step 2 is proposed to have been 
beneficial to males but costly to females.  
The quantitative relations between benefits and costs do not appear to have been 
explicitly stated in any of the verbal formulations of SAM. In fact, there has been a 
remarkable absence of any formal development of SAM. I will not attempt such an 
analysis here, but will simply point out some unstated implications of SAM. Suppose that 
fitness w was a continuous function of z, the total level of expression of some factor with 
X-linked and Y-linked alleles 
 
w = f z ( )  (1) 
 
Further suppose that the fitness of both sexes was maximized by a total level of 
expression z* toward which X-linked and Y-linked alleles (call these alleles X1 and Y1) 
each contributed z*/2 prior to inactivation of the Y-linked allele.  
An inactivating mutation of the Y-linked allele, Ynull, would have caused X1Ynull males 
to express z*/2 rather than z*. Therefore, the difference in fitness between an X1Ynull male 
and an X1Y1 male would have been 
 
f
z*
2
! 
" 
# 
$ − f z* ( ) = Δwm < 0  (2) 
   19 
Here, ∆wm is a measure of the fitness hurdle that had to be overcome by genetic drift or 
hitch-hiking for Ynull to become established in the population (step 1).  
Now suppose that a cis-acting mutation, X2, caused a doubling of expression of the 
factor from its X-linked allele such that X2Ynull males now expressed z* whereas X1X2 
females expressed 3z*/2. Such a mutation would have had sexually-antagonistic effects: 
X2Ynull males would be more fit than X1Ynull males but X1X2 females would be less fit than 
X1X1 females. The difference in fitness between an X2Ynull male and an X1Ynull male would 
have been 
 
f z* ( )− f
z*
2
" 
# 
$ 
% = −Δwm > 0  (3) 
 
Thus, the substitution of X2 for X1 reverses the effect of the substitution of Ynull for Y1 (in 
males). However, the difference in fitness between between an X1X2 female and an X1X1 
female would have been 
 
f
3z*
2
! 
" 
# 
$ − f z* ( )= Δw f < 0  (4) 
 
The new mutation, X2, would have been expressed twice as frequently in females as in 
males. Therefore, X2 would have increased in frequency by natural selection (step 2) if  
 
2Δwf − Δwm > 0  (5) 
   20 
As X2 increased in frequency, some females would have received two copies and 
expressed 2z*. Clearly, whether X2 could have spread to fixation would have depended on 
the precise form of f(z). Inequality (5) implies that fitness must have declined more 
rapidly below, than above, the optimum expression level at z*. However, the more 
rapidly fitness declined below z*, the higher would have been the fitness hurdle that had 
to be overcome by the initial inactivating mutation Ynull.  
If X2 became established in a population, then females would have benefited from the 
origin of an inactivatable allele X3 that restored expression levels to z* in both sexes (step 
3). However, a fitness function that is relatively insensitive to expression above z* 
implies that increased expression in females would be only weakly deleterious, so that the 
compensatory down-regulation of X-linked expression in females would be only weakly 
selected. It could be argued that “X3” reduced expression in females at many X-linked 
loci with sexually antagonistic effects, such that the fitness effect of reducing expression 
at one locus was weak but the cumulative advantage of halving expression at all loci was 
strong. Yet, the invocation of multiple loci raises the question why the “X2” mutations at 
multiple X-linked loci should all have caused a roughly two-fold increase in expression 
such that a 50% reduction in expression at each locus is advantageous. (Why wouldn’t 
some of the “X2” mutations have increased expression by 20%, others by 40%, and so 
on?) These heuristic arguments do not prove that SAM cannot explain the origin of XCI, 
but they do suggest that the conditions for such a model to work are more constrained 
than has been tacitly assumed in previous verbal presentations of SAM. 
SAM has nothing to say about why dosage compensation in mammals was achieved 
by silencing one of the two X chromosomes of females, rather than by a symmetrical   21 
down-regulation of both X chromosomes (as occurs in Caenorhabditis; Kelley and 
Kuroda 1995). Under SAM, the mechanism of dosage compensation employed by a 
particular taxon is purely arbitrary. I have argued above that XCI is a curious means of 
achieving dosage compensation because it forgoes some of the benefits of diploidy and 
requires that identical sequences be expressed differently in a single nucleus. In 
mitigation of this last criticism, a number of writers have suggested that pXCI preceded 
rXCI and simply required that the inactivation of the X chromosome that occurs during 
normal male meiosis be maintained into the next generation (Lifschytz and Lindsley 
1972; Lyon 1974; Huynh and Lee 2001, 2005; Wu and Xu 2003). 
SAM argues that XCI evolved because of conflicting selective forces acting on 
expression level per allele in males and females. By contrast, PAM argues that X
M and X
P 
evolved differential expression because they were subject to divergent selective forces 
within females. That is, X
M was subject to selection for increased expression of demand 
inhibitors, whereas X
P was subject to selection for decreased expression. Therefore, 
differential expression of homologs is an intrinsic feature of PAM, rather than a special 
assumption of SAM. PAM was developed explicitly to address mammalian XCI whereas 
SAM was initially presented as a brief addendum to a model of the degeneration of the Y 
chromosome and the evolution of dosage compensation that was intended to apply to 
multiple origins of these phenomena in diverse taxa (Charlesworth 1978). PAM does not 
contest this broader model of the degeneration of the Y chromosome, but only its 
application to the evolution of XCI in an ancestral mammal.  
To reiterate features of the current model, PAM assumes that both X-linked alleles 
were active in an ancestral mammal prior to the origin of pXCI but is neutral about   22 
whether this ancestor already possessed a mechanism of dosage compensation that did 
not involve XCI; PAM is also neutral on the presence or absence in this ancestor of 
functional homologs of X-linked alleles on the Y chromosome; PAM accepts that XCI 
now performs an essential role in dosage regulation that is important for the maintenance 
of XCI. PAM does not invoke a need to equalize expression between the sexes, although 
this could be a factor favoring the spread of inactivation to loci not involved in the 
inhibition of demand. 
 
SEXUAL VS. PARENTAL ANTAGONISM ON THE X CHROMOSOME 
Sexual and parental antagonism are two sides of the same coin. A gene that is present 
in a male body in this generation is necessarily paternally-derived in the next generation, 
whereas a gene that is present in a female body in this generation is necessarily 
maternally-derived in the next. On the other hand, whether an allele at an autosomal locus 
is maternally or paternally derived provides no information about its associated sex in the 
current generation (or its parental origin and associated sex in the next generation). This 
is because both males and females have a madumnal and padumnal allele at each 
autosomal locus, and these alleles are distributed to offspring independently of the 
offspring’s sex. By contrast, parental origin provides information about current and future 
sex at X-linked loci because only females possess padumnal alleles. Therefore, a 
padumnal allele is necessarily present in a female body, and a madumnal allele is more 
likely to be transmitted to a female body than to a male body in the next generation. 
Moreover, a gene with male-limited expression is only expressed when maternally-
derived, whereas a gene that is only expressed when paternally-derived has female-  23 
limited expression. Thus, questions of sexual and parental antagonism are entangled at X-
linked loci. 
The effects of X-linked genes are predicted to be biased in favor of females (because 
an X-linked allele has spent two-thirds of its ancestry in females) and biased in favor of 
matrilines (because an X-linked allele has been transmitted by eggs twice as often as by 
sperm). By contrast, the average fitness effects of autosomal genes are predicted to be 
unbiased with respect to sex and parental origin. The relative importance of these two X-
linked biases is currently unclear. For example, there is purported to be an excess of 
genes promoting general intelligence on the human X chromosome (Lehrke 1972; Turner 
1996). An interesting evolutionary question arises if this excess is not simply an artifact 
of a greater ease of ascertainment for X-linked loci. Is the X chromosome 
disproportionately involved in the control of intelligence because, during the course of 
human evolution, incremental increases of intelligence have been of greater value to 
women than to men (sexual antagonism) or because they have been of greater value to 
matrilines than to patrilines (parental antagonism)? 
A recurrent suggestion has been that imprinting of X-linked loci may have a role in 
the development of sexual dimorphism. This has been suggested for marsupials (Cooper 
et al. 1993; Graves 1996), for humans (Skuse 1999), and for the entirely X-linked 
genomes of haplodiploid insects (Poirié et al. 1992). Iwasa and Pomiankowski (1999, 
2001) have argued that theoretical models and the available data are more consistent with 
imprinting of X-linked loci having evolved to achieve sexual dimorphism rather than to 
mediate evolutionary conflicts between madumnal and padumnal alleles. I believe this 
conclusion is premature: sexual and parental antagonism both need to be considered in   24 
models of X-linked imprinting. If female-limited expression is achieved by inactivating 
an allele when maternally-derived, the allele will thereby only be subject to selection for 
its effects on matrilineal inclusive fitness. One might ask however why female-limited 
expression should be achieved indirectly by inactivating madumnal alleles in both males 
and females, rather than directly by inactivating the single allele in males (good old-
fashioned unimprinted sex limitation). The model of Iwasa and Pomiankowski (2001) 
begs the question by assuming that imprinting is the only way of achieving sex-specific 
expression. 
A comparison between the phenotypic effects of genes on marsupial and eutherian X 
chromosomes has some potential to separate the effects of parental and sexual 
antagonism. This is because pXCI eliminates the predicted female bias in the effects of 
X-linked genes but accentuates the matrilineal bias. The matrilineal bias of X-linked 
genes is accentuated in marsupials because genes subject to pXCI are never exposed to 
selection for their effects when paternally derived (Haig 2000b). The female bias in the 
effects of X-linked genes is eliminated because madumnal X-linked alleles are equally 
likely to be present in male and female bodies. 
 
OVERVIEW 
Over the course of evolutionary time, some allelic substitutions at autosomal loci will 
have been associated with inclusive fitness benefits when paternally-derived that 
outweighed inclusive fitness costs when maternally-derived, whereas others will have 
been associated with the opposite pattern of antagonistic effects. As a result, autosomal 
loci as a class are not predicted to systematically favor matrilines or patrilines, and loci   25 
whose expression favors patrilines are likely to be intermingled with loci whose 
expression favors matrilines on individual autosomes. Therefore, autosomal imprinting is 
predicted to evolve locus-by-locus rather than involving the inactivation of entire 
chromosomes. Allelic substitutions at unimprinted X-linked loci however are predicted to 
have been biased in favor of matrilines. At matrilineally-biased loci with dosage-sensitive 
effects, natural selection favors the silencing of padumnal alleles. Therefore, parental 
antagonism is proposed to have provided an evolutionary force that favored the 
inactivation of the padumnal X chromosome (pXCI) in females of an ancestral mammal. 
Once pXCI had evolved, natural selection would have favored increased expression 
of genes on the madumnal X chromosome to reassert matrilineal interests. As a 
consequence, the activity of two X chromosomes came to be incompatible with 
successful development, and X chromosome inactivation had acquired an essential role in 
‘dosage compensation.’ However, the disadvantages of functional hemizygosity favored 
the replacement of pXCI by random X chromosome inactivation (rXCI). 
By this hypothesis, genomic imprinting and XCI have evolved in mammals because 
of genes that have asymmetric effects for matrilines and patrilines. In mammals, the 
symmetry of effects is broken by lactation, viviparity, and sex-biased dispersal (Haig 
2000b), with the costs of parental care being borne disproportionately by matrilines (in 
particular, by mothers). Asymmetric effects are absent when genetic actions affect only 
the individual in which a gene is expressed and the individual’s direct descendants, plus 
other individuals that are randomly selected from the population without regard to 
relatedness. These conditions are approximated by oviparous organisms without 
postzygotic parental care (such as Drosophila and Caenorhabditis). Therefore, significant   26 
effects of imprinting are not expected in such organisms, and dosage compensation (if it 
occurs) should involve mechanisms other than XCI. 
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